Related Experiment Video
Updated: Sep 28, 2026
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Application of medical guidelines for the prescription of statins]
C Chevalier1, P Giral, F Chinaud
1Service Médical Assurance-Maladie Ile-de-France, CNAMTS, 22, avenue Karl-Marx, 93016 Bobigny Cedex, France.
Insights
Statin therapy adherence is low, with high nonadherence rates observed in both new and long-term users. Improved implementation of clinical guidelines for coronary heart disease (CHD) prevention is necessary.
Area of Science:
- Cardiology
- Pharmacoeconomics
- Public Health
Context:
- Statins are widely prescribed for coronary heart disease (CHD) prevention due to proven efficacy and cost-effectiveness in high-risk patients.
- National guidelines for statin initiation and follow-up were established in 1996 based on cardiovascular risk stratification.
- Assessing adherence to these guidelines is crucial for optimizing CHD prevention strategies.
Purpose:
- To evaluate the appropriateness of statin use in clinical practice compared to 1996 ANDEM guidelines.
- To determine nonadherence rates in both new and long-term statin users regarding guideline criteria.
- To identify specific areas of nonadherence in statin therapy management.
Summary:
- A study of new and long-term statin users in the Ile-de-France region revealed high nonadherence rates (72.4% and 71.1% respectively).
- Nonadherence included failure to test LDL cholesterol, lack of prior dietary changes, and pre-treatment LDL levels below guideline thresholds.
- Long-term users, particularly those in secondary prevention, also showed significant nonadherence to LDL-C targets and dietary recommendations.
Impact:
- Findings indicate a substantial gap between established clinical guidelines and actual practice in statin therapy management.
- There is a critical need for improved implementation strategies to enhance guideline adherence and optimize CHD prevention.
- This study underscores the importance of regular monitoring and patient education to improve statin therapy effectiveness.
Background:
The efficacy of statins to prevent coronary heart disease (CHD) is well documented. This class of lipid-lowering drugs is now widely prescribed and was demonstrated to be cost effective in high risk patients.
Objective:
To assess the appropriateness of statins use, regarding initiation and follow-up of the treatment, as compared to the guidelines elaborated in 1996 by National Agency for the Development of Medical Evaluation (ANDEM). These guidelines were based on stratification of patients according to cardiovascular risk.
Methods:
Two groups of patients living in Ile-de-France region were defined, using Health Insurance computer database, on reimbursements. The first group named "new users" included patients in whom statin therapy was initiated during March 2000. The second group named "long term users" included patients who have been treated by statin therapy for one year or more. A sample of patients were randomly selected among these two groups. Trained Health Insurance advisors analyzed in depth the patients medical history and diet. All biological results were recorded and a complete history of medical therapy was assessed for each patient. An algorithm allowed the advisor to rate for nonadherence according to French medical guidelines.
Results:
"New users": the random sample consisted of 460 patients, among whom 398 (87%) were free of CHD in whom the nonadherence rate was 72.4% (68.0% to 76.8%). Nonadherence concerned: LDL cholesterol level not tested (32%) and/or absence of prior fat-free diet (37%) and/or LDL cholesterol value before drug therapy was below the guidelines/threshold. "Long term users": the random sample consisted of 582 patients, among whom 381 (65%) were free of CHD. The nonadherence rate was 71.1% (66.5% to 75.7%). In addition, the nonadherence rate for patients in secondary prevention was 82.1% (79.7% to 84.6%) respectively, corresponding to: LDL cholesterol level not tested (41% and 34%); and/or no change dietary (18% and 12%); and/or unreach the LDL-C target level (24% and 45%).
Conclusion:
This study shows that the implementation of guidelines needs to be improved in clinical practice.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
01:26Atherosclerosis III: Management
01:26Coronary Artery Disease IV: Preventive Measures
01:26Angina IV: Management
01:27Coronary Artery Disease V: Interprofessional Care
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment